Abstract
Functional serotonin (5-hydroxytryptamine, 5-HT) receptors have been divided into three subtypes: 5-HT1,-like, 5-HT2 and 5-HT3, (ref. 1). Brain binding sites have been identified for both the 5-HT1, and 5-HT2 subtypes. Receptors of the 5-HT3 type have been characterized on isolated peripheral tissue models such as the rat vagus nerve2, guinea-pig ileum3 and isolated rabbit heart4. Using these models, selective 5-HT3 receptor antagonists such as MDL 72222 (ref. 5), ICS 205-930 (ref. 6), GR38032F (ref. 7) and BRL 43694 (ref. 8) have been developed. Recently, GR38032F, MDL 72222 and ICS 205-930 have been shown to have behavioural effects in rodents and primates that undoubtedly reflect an action in the central nervous system (refs 9–11 and unpublished observations), suggesting the existence of 5-HT3 receptors in the brain. Here we report direct evidence for the existence of 5-HT3 receptors in rat brain tissue and their distribution, based on high affinity binding of the potent 5-HT3 receptor antagonist 3H-GR65630 to homogenates of rat entorhinal cortex. Selective 5-HT3 receptor antagonists and agonists inhibited binding of 3H-GR65630 with high affinities which correlated well with their actions on the rat isolated vagus nerve2. Binding was differentially distributed throughout the brain with high concentrations in cortical and limbic areas.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
1. Bradley, P. B. et al. Neuropharmacology 25, 563-576 (1986). 2. Ireland, S. J. & Tyers, M. B. Br. J. Pharmac. 90, 229-238 (1987). 3. Bucheit, K. H., Engel, G., Mutschler, E. & Richardson, B. P. Naunyn-Schmiedebergs Arch. Pharmac. 329, 36-41 (1985). 4. Fozard, J. R., Mobarok Ali, A. T. M. & Newgrosh, G. Eur. J. Pharmac. 59,195-210 (1979). 5. Fozard, J. R. Naunyn-Schmiedebergs Arch. Pharmac. 326, 36-44 (1984). 6. Richardson, B. P., Engel, G., Donatsch, P. & Stadler, P. A. Nature 316, 126-131 (1985). 7. Brittain, R. T. et al. Br. J. Pharmac. 90, 87P (1987). 8. Fake, C. S., King, F. D. & Sanger, G. J. Br. J. Pharmac. 91, 335P (1987). 9. Jones, B. J., Oakley, N. R. & Tyers, M. B. Br. J. Pharmac. 90, 88P (1987). 10. Hagan, R. M. et al. Eur. J. Pharmac. 138, 303-305 (1987). 11. Costall, B., Domeney, A. M., Kelly, M. E., Naylor, R. J. & Tyers, M. B. Br. J. Pharmac. 90, 89P (1987). 12. File, S. E. J. Neurosci. Meth. 2, 219-238 (1980). 13. Munson, P. J. & Rodbard, D. Analyt. Biochem. 107, 220-230 (1980). 14. Richardson, B. P. & Engel, G. Trends Neurosci. 9, 424-428 (1986). 15. Paxinos, G. & Watson, C. The Rat Brain in Stereotaxic Coordinates (Academic, New York, 1982). 16. Rang, H. Proc. R. Soc., Lond. B 164, 488-510 (1966).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kilpatrick, G., Jones, B. & Tyers, M. Identification and distribution of 5-HT3 receptors in rat brain using radioligand binding. Nature 330, 746–748 (1987). https://doi.org/10.1038/330746a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/330746a0
This article is cited by
-
Serotonin and beyond—a tribute to Manfred Göthert (1939-2019)
Naunyn-Schmiedeberg's Archives of Pharmacology (2021)
-
Building a 5-HT3A Receptor Expression Map in the Mouse Brain
Scientific Reports (2017)
-
Antiemetics: an update and the MASCC guidelines applied in clinical practice
Nature Clinical Practice Oncology (2008)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.